Pacira Pharmaceuticals, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2015
For the full year, the company's EXPAREL sales were an estimated $239.9 million, an increase of 27% compared with $188.5 million in 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 USD | -1.78% |
|
+3.20% | -37.79% |
1st Jan change | Capi. | |
---|---|---|
-37.79% | 977M | |
+55.35% | 815B | |
+32.36% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.17% | 247B | |
+14.98% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |